Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0000950123-11-026581

Material agreement · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading y04669e8vk.htm…